CLEARTALENT LIMITED
Company number 08142795 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: CLEARTALENT LIMITED
1. Financial Health Score: F (Critical Condition)
ClearTalent Limited is in critical financial health. The company is deeply insolvent, with liabilities vastly exceeding its assets, and is suffering from severe cash flow asphyxiation having completely drained its cash reserves. Without immediate financial intervention, the company's ability to continue operating is in grave jeopardy.
2. Key Vital Signs
- Pulse (Liquidity): Extremely Weak. The current ratio is approximately 0.12 (£78,907 / £628,469). The company has only 12p in current assets for every £1 of short-term liabilities. This indicates a severe inability to meet near-term obligations as they fall due.
- Blood Pressure (Solvency): Dangerously Low. Net assets stand at a negative £694,546. The financial pressure is immense, with total liabilities (£773,453) outweighing total assets (£78,907) by a factor of nearly 10 to 1.
- Blood Sugar (Cash Reserves): Flatlined. Cash at bank has dropped to £0, down from £48,313 in 2024 and £183,317 in 2023. The business has no financial energy reserves to fall back on.
- Cholesterol (Deferred Income/Debt): High Blockage. Current liabilities include a staggering £480,001 in "accruals and deferred income." While this is money already in the bank for services not yet delivered (meaning it doesn't require future cash to pay off, unlike a bank loan), it represents a massive operational blockage that must be cleared through service delivery.
- Weight Loss (Asset Erosion): Alarming. Total assets have shrunk from £318,354 in 2024 to just £78,907 in 2025. The company is rapidly shedding its asset base.
3. Diagnosis
The patient is suffering from acute insolvency compounded by cash flow asphyxiation.
Looking at the patient's medical history, ClearTalent was financially healthy as recently as 2020/2021, boasting positive net assets of over £220,000. However, the business has suffered a dramatic collapse over the last four years, hemorrhaging value and accumulating massive liabilities.
The primary driver of the massive liabilities is £480,001 in deferred income. This means clients have paid upfront for services that ClearTalent has not yet delivered. In accounting terms, this is treated as a liability, but it is important to understand the nature of this "debt": the company owes services, not cash. If the company can deliver these services, it will convert this liability into revenue.
However, the immediate symptom of concern is the flatlined cash reserve (£0). Delivering those owed services requires cash to pay staff and overheads, and right now, the company has no liquidity to fuel its operations. Furthermore, the directors extracted £55,000 in consulting fees during the year, which is an unusual drain on resources given the critical financial condition of the business. The directors have signed off the accounts on a "going concern" basis, likely relying on their willingness to defer repayment on their £78,503 in director loans, but this is life-support at best.
4. Recommendations
To stabilize the patient and prevent terminal decline, the following emergency interventions are required:
- Immediate Cash Transfusion: The company urgently needs an injection of working capital. This should be facilitated immediately via further directors' loans or a formal equity injection to ensure payroll and essential operating expenses can be met.
- Convert Deferred Income to Revenue: The £480,001 in deferred income represents the company's primary route to recovery. Management must focus all available resources on fulfilling these outstanding obligations to "clear the blockage" and recognize this as earned revenue without incurring additional costs.
- Review Director Remuneration: Given the £0 cash balance and severe insolvency, the payment of £55,000 in consulting fees to directors/shareholders represents a significant hemorrhage. Director compensation must be restructured or suspended until the company achieves positive cash flow.
- Creditor Triage: With £628,469 in current liabilities, the company cannot hope to pay all its debts as they fall due. Management must prioritize creditor payments, focusing on keeping the lights on (trade creditors, taxes) while negotiating extended payment terms for non-essential debts.
- Formal Solvency Review: The directors should seek immediate professional advice to ensure they are not trading whilst insolvent, which carries significant legal risks. Their assertion of going concern rests entirely on their continued financial support, which must be formally documented.